Pharmaceutical Advisory Committee
( Last Updated : January 23, 2020)
The Pharmaceutical Advisory Committee comprises representatives from the federal, provincial, and territorial publicly funded drug plans and other related health organizations. The Pharmaceutical Advisory Committee provides strategic advice on drug policy issues, including cancer-specific issues and drug topics, to CADTH and its Board. Committee members also facilitate the effective jurisdictional sharing of drug policy information.
Chair |
|
|---|---|
|
Ontario Health |
Scott Gavura |
Members |
|
|
Government of Manitoba |
Patricia Caetano |
|
Saskatchewan Ministry of Health |
Rachel Cheruvallath |
|
British Columbia Ministry of Health |
Tijana Fazlagic |
|
British Columbia Cancer Agency |
Helen Anderson |
|
Alberta Health |
Andrea Nagle |
|
Ontario Ministry of Health |
Angie Wong |
|
Nova Scotia Department of Health and Wellness |
Kathleen Coleman |
|
New Brunswick Ministry of Health |
Position Vacant |
|
Prince Edward Island Department of Health and Wellness |
Marsha Cusack |
|
Newfoundland and Labrador Department of Health and Community Services |
Pam Barnes |
|
Nova Scotia Cancer Care Program |
Joanne Houlihan |
|
Government of Yukon Territory |
Marie-Claire Savoie |
|
Government of Nunavut |
Donna Mulvey |
|
Government of North West Territories |
Luke Spooner |
|
NIHB |
Susan Pierce |
|
Federal Drug Plans |
Harold Boudreau |
|
Health Canada |
Samir Khan |
|
Hospital/Health Authority |
Jeremy Slobodan |
|
Forces |
Michelle Sullivan |
|
CAPCA |
Gunita Mitera |
|
INESSS |
Sylvie Bouchard |
|
pCPA |
Dominic Tan |
|
PMPRB |
Tanya Potashnik |